MXPA05000467A - Formulacion de micoplasma gallisepticum. - Google Patents

Formulacion de micoplasma gallisepticum.

Info

Publication number
MXPA05000467A
MXPA05000467A MXPA05000467A MXPA05000467A MXPA05000467A MX PA05000467 A MXPA05000467 A MX PA05000467A MX PA05000467 A MXPA05000467 A MX PA05000467A MX PA05000467 A MXPA05000467 A MX PA05000467A MX PA05000467 A MXPA05000467 A MX PA05000467A
Authority
MX
Mexico
Prior art keywords
bird
strain
protective
formulation
amount
Prior art date
Application number
MXPA05000467A
Other languages
English (en)
Spanish (es)
Inventor
Naola Ferguson
Original Assignee
Univ Georgia Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia Res Found filed Critical Univ Georgia Res Found
Publication of MXPA05000467A publication Critical patent/MXPA05000467A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MXPA05000467A 2002-07-13 2003-07-10 Formulacion de micoplasma gallisepticum. MXPA05000467A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/194,180 US7217420B2 (en) 2002-07-13 2002-07-13 Mycoplasma gallisepticum formulation
PCT/US2003/022011 WO2004006851A2 (en) 2002-07-13 2003-07-10 Mycoplasma gallisepticum formulation

Publications (1)

Publication Number Publication Date
MXPA05000467A true MXPA05000467A (es) 2005-09-30

Family

ID=30114683

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05000467A MXPA05000467A (es) 2002-07-13 2003-07-10 Formulacion de micoplasma gallisepticum.

Country Status (11)

Country Link
US (2) US7217420B2 (https=)
EP (1) EP1531861A4 (https=)
JP (1) JP2005533116A (https=)
KR (1) KR20050074428A (https=)
CN (1) CN1688336A (https=)
AU (1) AU2003267992A1 (https=)
BR (1) BR0312640A (https=)
MX (1) MXPA05000467A (https=)
RU (1) RU2005104100A (https=)
WO (1) WO2004006851A2 (https=)
ZA (1) ZA200500169B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080026386A1 (en) * 2006-03-31 2008-01-31 Behrens Timothy W Irf-5 haplotypes in systemic lupus erythematosus
TWI422594B (zh) * 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains
MX2011007732A (es) * 2009-01-22 2011-11-04 Univ Georgia Formulacion de mycoplasma gallisepticum.
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
AU2014234452B2 (en) * 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
CN119816588A (zh) * 2022-04-06 2025-04-11 乔治亚大学研究基金公司 鸡毒支原体活疫苗

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137306A (en) 1966-07-11 1968-12-18 Research Corp Inoculum for poultry
JPS52134019A (en) 1976-04-28 1977-11-09 Biseibutsu Kagaku Kenkiyuushiy Micoplasma galicepticum infection vaccine
US5004607A (en) 1987-08-25 1991-04-02 University Of Georgia Research Foundation, Inc. Method of immunizing poultry
ES2058237T3 (es) 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
CA1339260C (en) 1988-06-02 1997-08-12 Kazumi Kodama Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
WO1993024646A1 (fr) 1992-05-29 1993-12-09 Nippon Zeon Co., Ltd. Antigene de mycoplasme aviaire, son gene, vecteur recombine contenant ledit gene, et vaccin prepare a l'aide de celui-ci
AU691175B2 (en) 1993-03-31 1998-05-14 Nippon Zeon Co., Ltd. Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
ATE196773T1 (de) 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
JPH07133295A (ja) 1993-08-27 1995-05-23 Nippon Zeon Co Ltd 新規な抗原タンパク質、その遺伝子、及び組み換えバキュロウイルスとその利用
JPH07228542A (ja) 1994-02-18 1995-08-29 Nippon Seibutsu Kagaku Kenkyusho 不活化病原体の鶏用気管内投与ワクチン
EP0802796B1 (en) 1995-01-06 2001-10-04 Akzo Nobel N.V. Chicken anaemia agent broiler vaccine
ZA978434B (en) 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.

Also Published As

Publication number Publication date
ZA200500169B (en) 2006-06-28
BR0312640A (pt) 2005-06-28
EP1531861A4 (en) 2006-10-11
WO2004006851A2 (en) 2004-01-22
KR20050074428A (ko) 2005-07-18
AU2003267992A1 (en) 2004-02-02
EP1531861A2 (en) 2005-05-25
US7217420B2 (en) 2007-05-15
US20040009179A1 (en) 2004-01-15
JP2005533116A (ja) 2005-11-04
AU2003267992A8 (en) 2004-02-02
WO2004006851A3 (en) 2004-03-18
US20060257414A1 (en) 2006-11-16
CN1688336A (zh) 2005-10-26
RU2005104100A (ru) 2005-08-27

Similar Documents

Publication Publication Date Title
Blackall et al. Infectious coryza and related bacterial infections
Sandhu Riemerella anatipestifer infection
EP2214702B1 (en) Mycoplasma bovis vaccine and methods of use thereof
Boulianne et al. Pasteurellosis and other respiratory bacterial infections
WO2012092226A1 (en) Veterinary vaccine composition against infections caused by salmonella
CN119816588A (zh) 鸡毒支原体活疫苗
Hafez et al. Ornithobacterium rhinotracheale infection
EP2389433B1 (en) Mycoplasma gallisepticum formulation
US7217420B2 (en) Mycoplasma gallisepticum formulation
HK1161289B (en) Mycoplasma gallisepticum formulation
AU2008318793B2 (en) Mycoplasma bovis vaccine
WO1994005783A1 (en) Novel haemophilus organism and vaccines containing the same
Limsatanun Development of inactivated mycoplasma gallisepticum vaccine in chickens